Sale!

GHRP-6 – 5mg

$22.99

5 mg per vial

0.0
Rated 0.0 out of 5
0.0 out of 5 stars (based on 0 reviews)
Excellent0%
Very good0%
Average0%
Poor0%
Terrible0%
Hurry! only 22 left in stock.
Add to Wishlist
Add to Wishlist
FREE & FAST SHIPPING
PUREST QUALITY
EXCELLENT SERVICE

Leave A Review

There are no reviews yet. Be the first one to write one.

Properties

Molecular Formula

C46H56N12O6

Molecular Weight873.0
Monoisotopic Mass872.44457755
Polar Area301
Complexity1570
XLogP1.9
Heavy Atom Count64
Hydrogen Bond Donor Count11
Hydrogen Bond Acceptor Count9
Rotatable Bond Count23
Physical AppearanceClear Liquid
StabilityLyophilized protein is to be stored at -20°C. It is recommended to aliquot the reconstituted (dissolved) protein into several discrete vials in order to avoid repeated freezing and thawing. Reconstituted protein can be stored at 4°C
PubChem LCSS

GHRP-6 Laboratory Chemical Safety Summary

Identifiers

CID9919153
CAS87616-84-0
InChIInChI=1S/C46H56N12O6/c1-27(54-44(62)39(20-29-23-51-35-15-7-5-13-32(29)35)57-43(61)34(48)22-31-25-50-26-53-31)42(60)56-40(21-30-24-52-36-16-8-6-14-33(30)36)46(64)58-38(19-28-11-3-2-4-12-28)45(63)55-37(41(49)59)17-9-10-18-47/h2-8, 11-16, 23-27, 34, 37-40, 51-52H, 9-10, 17-22, 47-48H2, 1H3, (H2, 49, 59)(H, 50, 53)(H, 54, 62)(H, 55, 63)(H, 56, 60)(H, 57, 61)(H, 58, 64)/t27-, 34-, 37-, 38+, 39+, 40-/m0/s1
InChIKeyWZHKXNSOCOQYQX-FUAFALNISA-N
Isomeric SMILESC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CC6=CN=CN6)N
Canonical SMILESCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC6=CN=CN6)N
IUPAC Name(2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide

Description

Description – GHRP-6

Growth Hormone Releasing Peptide 6 (GHRP-6) is a synthetic, 6-amino acid sequence, which is analogous to the naturally occurring protein met-enkephalin1. GHRP-6 is a member of a classification of agents called growth hormone (GH) secretagogues that were collectively developed in an effort to artificially stimulate the release of GH2. GHRP-6 is known to bind with the GH secretagogue receptor (ghrelin receptor) directly3, stimulating potent GH secretion and appetite in animal test subjects2.The promotion of improved strength, increased muscle mass to body fat ratio, and the encouragement of good joint and connective tissue health has been observed in animal trials4. Studies in animal test subjects show that GHRP-6 stimulates Ghrelin, “the hunger hormone” through its ghrelin receptor, which in turn signals an increased production of growth hormone (GH) by acting at the level of the pituitary or hypothalamus through a specific receptor different from that of the endogenous Growth Hormone-Releasing Hormone GHRH.The four parts of the animal test subjects that demonstrate the role of GHRP-6 include the pituitary gland, central nervous system, liver, and stomach.

Product Comparison

Similar to other agents of GH release, GHRP-6 acts on the anterior pituitary gland5. In spite of having a similar site of action, GHRP-6 does not stimulate GH production using the same biochemical pathway as the popular GH secretagogue ‘sermorelin’ its analogues, like CJC-12956. In light of this observation, it has been possible for researchers to administrate CJC-1295 and GHRP-6 concurrently in order to achieve an additive positive effect on GH release. A similar synergistic relationship has been documented with insulin, where much improved GH release was observed in animal trials following a concurrent dosing scheme7.

The GHRP Family

The GHRP family of proteins is distinct from growth hormone releasing hormones (GHRH or GHRF) in that they share no sequence relation and derive their function through action at a completely different receptor, the ghrelin receptor8. The GHRP family is unique in that they lack opiate activity, though they are analogues of species that bear this quality9.


Synonyms:

Growth Hormone Releasing Peptide-6; Growth hormone releasing hexapeptide; Somacrin; Somatocrinin-6; RP6;

Peer-Reviewed Sources:

  1. McDowell RS, Elias KA, Stanley MS, Burdick DJ, Burnier JP, Chan KS, Fairbrother WJ, Hammonds RG, Ingle GS, Jacobsen NE (1995). Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation. Proc Natl Acad Sci USA, 92:11165-11169. ↩︎
  2. Fairhall, K. M., Mynett, A., & Robinson, I. C. A. F. (1995). Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. Journal of Endocrinology, 144(3), 555-560. ↩︎
  3. Muccioli, G., Ghe, C., Ghigo, M. C., Papotti, M., Arvat, E., Boghen, M. F., Nilsson, H., Deghenghi, R., Ong, H., & Ghigo, E. (1998). Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. Journal of Endocrinology, 157(1), 99-106. ↩︎
  4. Cella, S. G., Cerri, C. G., Daniel, S., Sibilia, V., Rigamonti, A., Cattaneo, L., Deghenghi, R., & Müller, E. E. (1996). Sixteen weeks of hexarelin therapy in aged dogs: effects on the somatotropic axis, muscle morphology, and bone metabolism. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 51(6), B439-B447. ↩︎
  5. Mau, S. E., Witt, M. R., Bjerrum, O. J., Særmark, T., & Vilhardt, H. (1995). Growth hormone releasing hexapeptide (GHRP-6) activates the inositol (1, 4, 5)-trisphosphate/diacylglycerol pathway in rat anterior pituitary cells. Journal of Receptors and Signal Transduction,15(1-4), 311-323. ↩︎
  6. Cordido, F., Penalva, A., Dieguez, C., & Casanueva, F. F. (1993). Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. The Journal of Clinical Endocrinology & Metabolism, 76(4), 819-823. ↩︎
  7. Penalva, A., Carballo, A., Pombo, M., Casanueva, F. F., & Dieguez, C. (1993). Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. The Journal of Clinical Endocrinology & Metabolism, 76(1), 168-171. ↩︎
  8. Granado, M., Priego, T., Martín, A. I., Villanua, M. A., & López-Calderón, A. (2005). Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. American Journal of Physiology-Endocrinology and Metabolism, 288(3), E486-E492. ↩︎
  9. Casanueva, F. F., & Dieguez, C. (1999). Growth hormone secretagogues: physiological role and clinical utility. Trends in Endocrinology & Metabolism,10(1), 30-38. ↩︎

ALL LITERATURE, INFORMATION, AND DATA, PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

Accurate research is our priority.

Same Day Shipping

Enjoy the convenience of receiving your order swiftly. We offer same-day shipping on all orders of in-stock items placed before 12:00 pm EST.

Dedicated Service

Our dedicated team is always at your service, Ready to assist you with any customer service requests you may have. We prioritize your satisfaction and aim to provide a seamless experience.

Free Shipping

To enhance your shopping experience, We offer free shipping on all orders totaling $100 or more. Rest assured, we've got you covered!

Purist Quality

We take pride in ensuring the utmost purity of our products. Every item we offer undergoes rigorous lab testing and is certified for the highest possible purity.

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping